🔎 Trials Near Me

Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Distaarikii Koloombiyaa

Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Distaarikii Koloombiyaa keessatti

Qorannoo 7 Kansera Urothelial (Cell Transitional) f Distaarikii Koloombiyaa keessatti hirmaatuu jiru.

Magaalota Distaarikii Koloombiyaa keessatti

Takkalaa qorannoo (Ingiliffa)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • MedStar Georgetown University Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Sibley Memorial Hospital Pharmacy Department, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • MedStar Washington Hospital Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07218380

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

  • Research Site, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07815665

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  • Medstar Washington Hospital Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06774131

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • Medstar Washington Hospital Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04879329

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.